Edmond De Rothschild Holding S.A. Gilead Sciences, Inc. Transaction History

Edmond De Rothschild Holding S.A.

  • $5.7 Billion
  • Q4 2024

A detailed history of Edmond De Rothschild Holding S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 7,315 shares of GILD stock, worth $848,466. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,315
Previous 7,315 -0.0%
Holding current value
$848,466
Previous $613,000 10.11%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$66.59 - $83.99 $9,655 - $12,178
-145 Reduced 1.94%
7,315 $613,000
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $13.5 Million - $15.6 Million
-214,222 Reduced 96.63%
7,460 $511,000
Q1 2024

May 08, 2024
SELL
$71.58 - $87.29 $133,210 - $162,446
-1,861 Reduced 0.83%
221,682 $16.2 Million
Q4 2023

Feb 12, 2024
SELL
$73.27 - $83.09 $32,824 - $37,224
-448 Reduced 0.2%
223,543 $18.1 Million
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $1.72 Million - $1.88 Million
23,322 Added 11.62%
223,991 $16.8 Million
Q1 2023

May 11, 2023
SELL
$77.31 - $88.08 $15.6 Million - $17.8 Million
-202,244 Reduced 50.2%
200,669 $16.6 Million
Q4 2022

Feb 09, 2023
SELL
$62.32 - $89.47 $3.18 Million - $4.56 Million
-50,970 Reduced 11.23%
402,913 $34.6 Million
Q3 2022

Nov 09, 2022
SELL
$59.54 - $68.01 $1.06 Million - $1.21 Million
-17,779 Reduced 3.77%
453,883 $28 Million
Q2 2022

Aug 12, 2022
SELL
$57.72 - $65.01 $2.69 Million - $3.03 Million
-46,679 Reduced 9.01%
471,662 $29.2 Million
Q1 2022

May 10, 2022
SELL
$57.92 - $72.58 $1.14 Million - $1.43 Million
-19,683 Reduced 3.66%
518,341 $30.8 Million
Q4 2021

Feb 10, 2022
SELL
$64.88 - $73.64 $8.87 Million - $10.1 Million
-136,753 Reduced 20.27%
538,024 $39.1 Million
Q3 2021

Nov 12, 2021
SELL
$67.69 - $73.03 $2.77 Million - $2.99 Million
-40,988 Reduced 5.73%
674,777 $47.1 Million
Q2 2021

Aug 11, 2021
BUY
$63.47 - $69.35 $5.09 Million - $5.56 Million
80,215 Added 12.62%
715,765 $49.3 Million
Q1 2021

May 17, 2021
BUY
$60.0 - $68.46 $1.62 Million - $1.84 Million
26,942 Added 4.43%
635,550 $41.1 Million
Q4 2020

Feb 12, 2021
SELL
$56.65 - $64.55 $636,462 - $725,219
-11,235 Reduced 1.81%
608,608 $35.5 Million
Q3 2020

Nov 12, 2020
BUY
$62.1 - $78.08 $299,446 - $376,501
4,822 Added 0.78%
619,843 $39.2 Million
Q2 2020

Aug 07, 2020
SELL
$72.34 - $84.0 $193,871 - $225,120
-2,680 Reduced 0.43%
615,021 $47.3 Million
Q1 2020

May 15, 2020
SELL
$62.63 - $80.22 $16.1 Million - $20.6 Million
-256,658 Reduced 29.35%
617,701 $46.2 Million
Q4 2019

Feb 14, 2020
SELL
$61.62 - $67.78 $5.45 Million - $5.99 Million
-88,389 Reduced 9.18%
874,359 $56.8 Million
Q3 2019

Nov 14, 2019
SELL
$62.51 - $69.0 $4.82 Million - $5.32 Million
-77,172 Reduced 7.42%
962,748 $61 Million
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $3.27 Million - $3.67 Million
-52,847 Reduced 4.84%
1,039,920 $70.3 Million
Q1 2019

May 13, 2019
BUY
$62.53 - $70.05 $1.89 Million - $2.11 Million
30,153 Added 2.84%
1,092,767 $71 Million
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $3.41 Million - $4.45 Million
56,382 Added 5.6%
1,062,614 $66.5 Million
Q3 2018

Nov 14, 2018
SELL
$71.28 - $78.92 $7.85 Million - $8.69 Million
-110,133 Reduced 9.87%
1,006,232 $77.7 Million
Q2 2018

Aug 14, 2018
BUY
$64.88 - $75.68 $253,745 - $295,984
3,911 Added 0.35%
1,116,365 $79.1 Million
Q1 2018

May 15, 2018
SELL
$72.84 - $88.8 $10 Million - $12.2 Million
-137,739 Reduced 11.02%
1,112,454 $83.9 Million
Q4 2017

Feb 14, 2018
SELL
$71.15 - $83.52 $8.66 Million - $10.2 Million
-121,659 Reduced 8.87%
1,250,193 $89.6 Million
Q3 2017

Nov 13, 2017
BUY
$72.11 - $85.47 $98.9 Million - $117 Million
1,371,852
1,371,852 $111 Million

Others Institutions Holding GILD

# of Institutions
2,099
Shares Held
1.02B
Call Options Held
8.73M
Put Options Held
9.63M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $145B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email